Search filters

List of works by Anna Sureda

Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.

scientific article published on 9 February 2018

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.

scientific article published on 12 April 2018

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

scientific article published on 19 March 2015

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

article

Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experience

scientific article published on 23 May 2020

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

scientific article

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

scientific article published on 01 October 2013

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

scientific article published on 21 April 2020

Is Post-Transplant Cyclophosphamide the New Methotrexate?

scholarly article

Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

scientific article published on 12 February 2020

Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

scientific article

Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma

scientific article published on 07 June 2018

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study

scientific article published on 30 July 2020

Paulina is supported by:

About Paulina

Help